Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Updated results from the frailty-stratified, randomised controlled bayesian adaptive trial of bortezomib versus lenalidomide in transplant ineligible myeloma (TI NDMM) – the FRAIL-m study (AMaRC 19-01; ALLG MM22)

Sueh-Li Lim, John Reynolds, Lucy Pemberton, Tricia Wright, Sophie Lee, Peter Mollee, Anita C. Shetty, Yu Jin Kim, Weston Helen, Byard Nina, Khoa Le, Zoe McQuilten, Hang Quach, Andrew Spencer

Blood (2025) 146 (Supplement 1): 5842.

https://doi.org/10.1182/blood-2025-5842

Published: 2025

Journal Articles

An immune-therapeutic salvage strategy for ‘functional’ high-risk (FHR) multiple myeloma (MM) incorporating iberdomide, isatuximab, and dexamethasone – the IBIS study amarc 20-01.

Sueh-Li Lim, Sridurga Mithraprabhu, John Reynolds, Wojciech Janowski, Noemi Horvath, Hang Quach, Philip Campbell, Georgia McCaughan, Yu Jin Kim, Thalia Peres Suarez, Sophie Lee, Phillip Wong, Byard Nina, Priyanka Meet, Khoa Le, Andrew Spencer

Blood (2025) 146 (Supplement 1): 5841.

https://doi.org/10.1182/blood-2025-5841

Published: 2025